Table 4.
Subgroup analysis of the association between MetS score and incident CVD.
| Subgroup | N | Events | HR | 95% CI | P value |
|---|---|---|---|---|---|
| Age <60 years | 4433 | 416 | 1.249 | 1.135–1.375 | <0.001 |
| Age ≥60 years | 3456 | 399 | 1.168 | 1.060–1.286 | 0.002 |
| Male | 3726 | 345 | 1.279 | 1.147–1.426 | <0.001 |
| Female | 4163 | 470 | 1.165 | 1.066–1.273 | <0.001 |
| Never smoker | 4796 | 513 | 1.196 | 1.098–1.302 | <0.001 |
| Former smoker | 647 | 77 | 1.332 | 1.052–1.686 | 0.017 |
| Current smoker | 2446 | 225 | 1.229 | 1.078–1.401 | 0.002 |
| CKM Stage 0 | 1620 | 105 | 1.410 | 0.950–2.091 | 0.088 |
| CKM Stage 2 | 5143 | 558 | 1.196 | 1.107–1.291 | <0.001 |
| CKM Stage 3 | 891 | 120 | 1.162 | 0.969–1.392 | 0.105 |
HR, hazard ratio; CI, confidence interval. Per 1-point increase in MetS score, adjusted for age, sex, marital status, education, smoking, drinking, BUN, creatinine, TC, LDL-C, CRP, uric acid, and platelet count. CKM Stage 1 (n = 235) not shown due to model convergence limitations. P for interaction: age = 0.087, sex = 0.815, CKM stage = 0.188.